EMEA (EUROPE, MIDDLE EAST AND AFRICA) ERYTHROPOIETIN MARKET 2017 FORECAST TO 2022

Jan 2018 116

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.

Scope of the Report:

This report focuses on the Erythropoietin in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

  • Amgen
  • Johnson & Johnson
  • Roche
  • Galenica
  • Emcure
  • Kyowa Hakko Kirin
  • 3SBio
  • Biocon
  • LG Life Sciences

Market Segment by Regions, regional analysis covers

  • Europe (Germany, France, UK, Russia, Italy and Turkey)
  • Middle East (Saudi Arabia, Israel, UAE and Iran)
  • Africa (South Africa, Nigeria, Egypt and Algeria)

Market Segment by Type, covers

  • Epoetin-alfa
  • Epoetin-beta
  • Darbepoetin-alfa
  • Others

Market Segment by Applications, can be divided into

  • Anemia
  • Kidney Disorders
  • Others

There are 13 Chapters to deeply display the EMEA Erythropoietin market.

Chapter 1, to describe Erythropoietin Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Erythropoietin, with sales, revenue, and price of Erythropoietin, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Erythropoietin, for each region, from 2012 to 2017;

Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 10, Erythropoietin market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 11, 12 and 13, to describe Erythropoietin research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source

Table of Contents

Related reports :

(Apr 18)

Vitamin K2 is the term for a group of compounds called ‘menaquinones,’ which can be found mainly in dairy products. All K vitamins are simil...

(Apr 18)

"Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by th...

(Apr 18)

"Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from l...

(Apr 18)

Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both ...

(Apr 18)

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent ...

(Apr 18)

Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at nigh...

EMEA (EUROPE, MIDDLE EAST AND AFRICA) ERYTHROPOIETIN MARKET 2017 FORECAST TO 2022


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*